Latest ![Pepper]()
XPOVIO is a new treatment for multiple myeloma
By PepperMar 31,
2021
Pepper
Born and raised in Riverside, Pepper is thrilled to be part of the station she grew up listening to! She serves as a weekend host, afternoon traffic…
March is Myeloma Awareness Month, and there is a positive and hopeful development in the treatment of this second most common blood cancer. In December, the FDA approved the first new treatment option in five years for multiple myeloma patients who have previously been treated with at least one other drug.
Dr. Michael Kauffman, M.D., PhD (CEO of Karyopharm which developed XPOVIO) and Dr. Sharon Shacham, PhD and MBA, discuss why this FDA-approved treatment is such an important development in the treatment of multiple myeloma, who is most likely to be diagnosed with multiple myeloma, and symptoms and treatments for the disease.
